REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Indofarma Tbk (Indonesia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pt Indofarma Tbk Profile Updated: March 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PT. Indofarma (Persero) Tbk. (INAF), operates as a state-owned enterprise that produce pharmaceuticals and health products. INAF's products are marketed both domestically and internationally. INAF manufactures and distributes pharmaceuticals products, including ethical and OTC products. INAF also markets and distributes health products. INAF's ethical products include generic medicines and trademarked medicines, while its OTC products are classified into: OTC medicines, herbal medicines and health food. INAF was listed on Indonesia Stock Exchange in 2001 under the Main Board. The company was founded in 1996 and based in Bekasi, West Java, Indonesia.

Headquarters
Jl. Tambak No.2, Manggarai
Jakarta; Jakarta; Postal Code: 13150

Contact Details: Purchase the Pt Indofarma Tbk report to view the information.

Website: http://www.indofarma.co.id

Basic Information
Total Employees:
Purchase the Pt Indofarma Tbk report to view the information.
Outstanding Shares:
Purchase the Pt Indofarma Tbk report to view the information.
Financial Auditors:
Purchase the Pt Indofarma Tbk report to view the information.
Incorporation Date:
1996
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
11.994%
Subsidiaries
Pt Indofarma Global Medika
99.99%
Company Performance
Financial values in the chart are available after Pt Indofarma Tbk report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
-50.75%
Total operating revenue
-50.88%
Operating profit (EBIT)
-40.26%
EBITDA
-57.27%
Net Profit (Loss) for the Period
-4.69%
Total assets
-17.72%
Total equity
N/A
Operating Profit Margin (ROS)
-22.52%
Net Profit Margin
-22.77%
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
-0.43%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?